year 17, Issue 3 (May - June 2023)                   Iran J Med Microbiol 2023, 17(3): 377-378 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mukhida S, Kannuri S, Das N, Khan S, Patil R. Is a Vaccine One of the Factors that Will Contribute to the End of the Pandemic?. Iran J Med Microbiol 2023; 17 (3) :377-378
URL: http://ijmm.ir/article-1-1985-en.html
1- Department of Microbiology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, Maharashtra, India
2- Department of Microbiology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, Maharashtra, India , ksr27081993@gmail.com
Abstract:   (984 Views)

The covid-19 pandemic began in China in November 2019 and spread globally by March 2020. In India Vaccine research, trials, and production were ramped up gradually. The Covishield vaccine trial was completed by December 2020 and the mass vaccination program started in January 2021. The mortality was far more in western and European countries (despite better health infrastructure) than in Asia or Africa. This shows how a virus can behave differently based on race. True reasons for the decline of the epidemic are still to be well established. Is it due to vaccines? Or is it just that the virus lethality has waned naturally so that it is now living in perfect sync with a human? Despite vaccines, many people suffered from breakthrough infections. When the rest of the world was recovering, China was a cause of worry. In spite of good vaccination coverage with an indigenous and efficacious vaccine, it caused havoc in the last 6 months. It may be related to their zero covid policy of theirs. Always remember that the virus will never vanish; it is still active someplace. When they have the opportunity to mutate, they will create new varieties and return.

Full-Text [PDF 359 kb]   (306 Downloads) |   |   Full-Text (HTML)  (162 Views)  
Type of Study: Letter to the Editor | Subject: Medical Virology
Received: 2023/01/12 | Accepted: 2023/05/25 | ePublished: 2023/06/26

References
1. Das NK, Prasanna S, Pandit P, Dudhat VL. How much can we rely on a scrambled COVID-19 vaccine? It is not the only way out!. Med J DY Patil Univ. 2022;15(Suppl 2):S353-S5. Available from: [https://www.mjdrdypv.org/preprintarticle.asp?id=358292]
2. Mukhida S, Vyawahare C, Verma P, Khan S, Das N. Are the Current COVID-19 Cases Post Phase of 3rd Wave or Pre-phase of 4th Wave in India? Iran J Med Microbiol 2023;17(2):270-2. [DOI:10.30699/ijmm.17.2.270]
3. Gupta A, Bhoyar R, Mirza S, Jolly B, Senthivel V, Shamnath A, et al. SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker. J Infect. 2022; 84(3):418-67. [DOI:10.1016/j.jinf.2021.10.008] [PMID] [PMCID]
4. Khan S, Mukhida S, Patil R, Mirza S, Ajagunde J, Das NK. I-, You-, and We-Centered Approach Toward Hygienic Hands. Asia Pac J Public Health. 2022;34(8):879-80. [DOI:10.1177/10105395221126009] [PMID]
5. Pfizer CEO tests positive for COVID for a second time published by REUTERS on September 25, 2022 [cited 2022 Dec 31]. Available from: [https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-ceo-tests-positive-covid-2022-09]
6. Morens DM, Folkers GK, Fauci AS, The Concept of Classical Herd Immunity May Not Apply to COVID-19, J Infect Dis. 2022;226(2):195-8. [DOI:10.1093/infdis/jiac109] [PMID] [PMCID]
7. Bhaumik S, MUKHIDA S, Das N, Khan S, Patil R, Kannuri S. Can Vaccines Alone Bring an End to This Pandemic?. Natl J Community Med. 2023;14(03):208-9.. [DOI:10.55489/njcm.140320232647]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc